Home
About
Publications Trends
Recent Publications
Expert Search
Archive
expanded programme on immunization (epi)
How can EPI be improved?
To further enhance the impact of EPI, the following measures can be considered:
Increasing
investment in immunization programmes
to ensure sustainable funding.
Enhancing
public-private partnerships
to leverage resources and expertise.
Strengthening
surveillance systems
to monitor disease outbreaks and vaccine coverage.
Addressing
vaccine hesitancy
through targeted communication strategies and community engagement.
Expanding the use of
digital health technologies
to improve data collection and analysis.
Frequently asked queries:
What is the Expanded Programme on Immunization (EPI)?
What are the goals of EPI?
Which vaccines are included in EPI?
How does EPI improve vaccine coverage?
What are the challenges faced by EPI?
What are the successes of EPI?
How can EPI be improved?
What is Poliovirus?
Why Is Cold Chain Management Critical?
What Is the Future of Vaccines?
What are the challenges faced by EPI?
What is the Role of Public Education in Vaccine Management?
How to Report to VAERS?
Are There Special Considerations for Type 1 and Type 2 Diabetes?
What is Vaccine Efficacy?
Why Focus on Measles and Rubella?
What is GIS?
Why Do People Hesitate to Get Vaccinated?
What are Some Examples of Antiviral Drugs?
How Are Vaccines Developed?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Cardiovascular Disease
Cholera Vaccination
Hepatitis B
Liver Diseases
Malaria Vaccine
Measles Surveillance
Measles Vaccination
Poliovirus
RNA vaccines
Vaccine Development
Vaccine Exemptions
Vaccine Storage
Partnered Content Networks
Relevant Topics
ACIP guidelines
AllopathicVaccines
Antiviral Therapy
Cardiovascular Disease
chemoprevention
childhood vaccines
Cholera
Chronic Conditions
Cirrhosis
COFs
covid 19 vaccine
COVID-19
COVID-19 vaccines
Cytokine Storm
cytomegalovirus
Diabetes
Drug delivery
exosome
genetic engineering
genomesequencing
Genomic
Geographic Information Systems (GIS) in surveillance
Global Health
Glycemic Control
HBsAg
HBV DNA
HBV vaccination
HCV vaccine development
health systems
Healthcare Management
Hepatitis B (HBV)
Hepatitis B Virus
Hepatitis C (HCV)
Hepatocellular carcinoma (HCC)
Herd immunity
Historical Measles Outbreaks
hydrophobic
Hygiene
Hyperglycemia
immune responses
Immunization
Immunization guidelines
immunizations
immunogenicity
Immunoprophylaxis
latency
Legal implications
lipid
Liver diseases
malaria prevention
Malaria vaccine development
Maternal Health
Measles and Rubella Initiative
Measles control strategies
Measles outbreaks
Measles surveillance
measles vaccination
Measles Vaccination Efficacy
Measles Vaccine Effectiveness
Measles Vaccine Review
Molecular diagnostics
monoclonal antibodies
Mother-to-Child Transmission
mRNA
mRNA vaccines
Multi-Dose
nanocarriers
nanoparticles
nanovaccine
Newborn vaccination
Oral Cholera Vaccine
Paralysis
Pertussis outbreaks
Philosophical exemptions
phylodynamics
physicals
polio vaccine
poliovirus
Polymerase Chain Reaction (PCR)
Preventive Measures
Public Health
Public health campaigns
Public health ethics
Recent Measles Outbreaks
Religious exemptions
RNA
RNA vaccines
RTS
S/AS01
SARS-CoV2
Single-Dose
Supplementary immunization activities (SIAs)
systems biology
Telemedicine
transcriptional profiling
vaccination
Vaccination programs
Vaccine
Vaccine coverage
vaccine derivative poliovirus
vaccine derived poliovirus
vaccine development
vaccine efficacy
Vaccine exemptions
Vaccine hesitancy
Vaccine Storage
Vaccine Transport
vaccine transportation
Vaccine-preventable diseases
VDPVs
WHO measles initiatives
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Vaccine.
Subscribe